metformin + placebo

Metformin + placebo refers to the combination of metformin, a biguanide antihyperglycemic agent, and an inert substance (placebo) used as a control in clinical trials. Metformin acts primarily by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. Placebo is pharmacologically inactive and serves as a comparator to assess the efficacy and safety of metformin in randomized controlled trials. This combination is not intended for therapeutic use but rather for research purposes to evaluate the effects of metformin versus no active treatment in various populations, most commonly patients with type 2 diabetes mellitus[1][2][6].

Other names

placebo and metforminmetformin plus placebo